Avanos Medical (AVNS) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.83% |
| Dec 31, 2025 | 11.07% |
| Sep 30, 2025 | 15.54% |
| Jun 30, 2025 | 5.35% |
| Mar 31, 2025 | 2.39% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | 3.09% |
| Jun 30, 2024 | 2.64% |
| Mar 31, 2024 | 8.85% |
| Dec 31, 2023 | 7.69% |
| Sep 30, 2023 | 15.89% |
| Jun 30, 2023 | 23.82% |
| Mar 31, 2023 | 20.11% |
| Dec 31, 2022 | 14.64% |
| Sep 30, 2022 | 18.28% |
| Jun 30, 2022 | 28.23% |
| Mar 31, 2022 | 33.10% |
| Dec 31, 2021 | 32.45% |
| Sep 30, 2021 | 38.07% |
| Jun 30, 2021 | 42.70% |
| Mar 31, 2021 | 21.01% |
| Dec 31, 2020 | 20.23% |
| Sep 30, 2020 | -2.72% |
| Jun 30, 2020 | -6.12% |
| Mar 31, 2020 | -9.46% |
| Dec 31, 2019 | -21.77% |
| Sep 30, 2019 | -35.23% |
| Jun 30, 2019 | -53.79% |
| Mar 31, 2019 | -28.25% |
| Dec 31, 2018 | -43.73% |
| Sep 30, 2018 | -54.11% |
| Jun 30, 2018 | -66.87% |
| Mar 31, 2018 | -6.91% |
| Dec 31, 2017 | -13.82% |
| Sep 30, 2017 | -41.68% |
| Jun 30, 2017 | -47.23% |
| Mar 31, 2017 | -58.70% |
| Dec 31, 2016 | -37.12% |
| Sep 30, 2016 | -25.37% |